Quick Takeaways
- SILVERARC CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G for Avalo Therapeutics, Inc. Class A Common Stock (AVTX).
- Disclosed ownership: 5.5%.
- Date of event: 30 Sep 2025.
SILVERARC CAPITAL MANAGEMENT, LLC - 30 Sep 2025 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Class A Common Stock (AVTX)
- Filing Manager
- SILVERARC CAPITAL MANAGEMENT, LLC
- Reporting Manager
- SilverArc Capital Management, LLC
- Symbol
- AVTX
- Shares outstanding
- 13,155,511 shares
- Disclosed Ownership
- 720,922 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 12:39:50 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"SILVERARC CAPITAL MANAGEMENT, LLC disclosed 5.5% ownership in Avalo Therapeutics, Inc. Class A Common Stock (AVTX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 12:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SilverArc Capital Management, LLC | 5.5% | 720,922 | 0 | 720,922 | Devesh S. Gandhi | Sole Member of SilverArc Capital Management, LLC | |
| Devesh Gandhi | 5.5% | 720,922 | 0 | 720,922 | Devesh S. Gandhi | Sole Member of SilverArc Capital Management, LLC |